SEC Form 4 · accession 0001493152-26-044250
Anixa Biosciences Inc · ANIX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Lewis H Titterton Jr.
Director
Period of report
Sep 23, 2026
Accepted (ET)
Sep 25, 2026 · 8:39 am EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0000715446
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Sep 23, 2026 | P | 49,036 | $2.69 | A | 1,046,003 | D |
Table II — derivative securities
No Table II lines on this filing.